© 2021 All rights reserved
Datavagyanik- Your Research Partner
The global Left Atrial Appendage Closure Devices Market size in is 2021 expected to be $– million and is expected to grow at –% CAGR during the period (2018-2021). The global Left Atrial Appendage Closure Devices Market is segmented into North America, Europe, APAC & Rest of the world.
The research report titled “Left Atrial Appendage Closure Devices Market, Business and Opportunity Analysis” published by Datavagyanik presents a detailed analysis of the Left Atrial Appendage Closure Devices Market with country-wise market statistics, qualitative insights, and market player analysis. One of the prime objectives of the report is to provide an assessment of the market potential, market revenue, growth and business opportunities for Left Atrial Appendage Closure Devices Market in each country.
North America Left Atrial Appendage Closure Devices Market size is expected to be – million and is expected to grow at a CAGR of –% during the period 2021 to 2028. US & Canada will drive the most of the revenue in the region. North America has a huge chunk of global market.
Europe Left Atrial Appendage Closure Devices Market Size is expected to be—million and is expected to grow at a CAGR of –%. APAC Left Atrial Appendage Closure Devices Market Size is Expected to grow at a CAGR of –. APAC will grow fastest as the market is still in its nascent stage.
Left atrial appendage closure devices are designed to close the left atrial appendage (LAA). The LAA is a small sac-like structure that protrudes from the heart’s left atrium and can harbor blood clots. These blood clots can break off and travel to the brain, causing a stroke. The LAA closure device is placed during a minimally invasive cardiac procedure called cardioversion and prevents clot formation in the LAA. This device is an important innovation for treating atrial fibrillation, affecting thousands worldwide.
Technological advances have led to the development of machine-learning devices that can process data quickly and efficiently. These devices use a variety of algorithms and deep learning methods to analyze data from multiple sources, enabling them to make conclusions based on pattern recognition. Their ability to interpret data accurately and quickly provides a range of benefits, such as improved decision-making abilities, increased accuracy in forecasting, more effective problem-solving strategies, faster speed of execution, and enhanced customer service capabilities. As these devices evolve through ongoing research and development, they increasingly find applications across medical industries, proving highly beneficial for businesses.
Left atrial appendage closure (LAAC) devices offer an alternative to lengthy anticoagulant therapies for people with atrial fibrillation. Currently, three LAAC devices are approved for clinical use – the WATCHMAN device, the Amplatzer Amulet device, and the Lariat device.
The WATCHMAN device is a conventional LAAC device consisting of a titanium frame and umbrella-shaped disk implanted in the left atrial appendage through a catheter.
The Amplatzer Amulet is a circular occluder powered by nitinol springs deployed from an outer sheath.
Finally, the Lariat device features an anchor molded into a snare loop that is placed over the neck of the left atrial appendage and tightened down to clamp off its opening.
Physicians continue to explore new opportunities in this field so that more individuals can achieve improved outcomes without long-term anticoagulant therapy.
The global LAAC devices market is expected to witness enormous growth over the forecast period. The growing prevalence of cardiovascular diseases, the growing geriatric population, and advancements in medical technology are the main reasons behind this substantial growth.
According to a report, the global left atrial appendage closure devices market is projected to grow at a CAGR of 8.3 percent between 2021 and 2027.
Increasing demand for minimally invasive surgeries, rising awareness about cardiovascular diseases, technological advancements in medical treatments, and government initiatives to improve healthcare infrastructure are some major factors driving this market’s growth.
High costs associated with LAAC procedures and the lack of skilled personnel to perform LAAC surgeries are some of the significant challenges faced by this market’s growth. Additionally, stringent regulations imposed on medical device approvals and inadequate reimbursement policies for these procedures further hinder its growth potential. However, despite these challenges, favorable reimbursement policies in developed countries such as USA and Germany are likely to propel its demand over the forecast period.
Moreover, increased investments in research & development activities by key players operating in this market will offer significant opportunities for its growth over the coming years. For instance, Abbott Laboratories has recently introduced a new series of Watchman left-atrial appendage closure (LAAC) devices designed for people with non-valvular atrial fibrillation that can significantly reduce their risk of stroke compared with warfarin therapy alone. This new device further enhances Abbott’s portfolio of LAAC devices, which have been clinically effective for reducing stroke risk compared to warfarin therapy alone. Similarly, other key players, such as Boston Scientific Corporation and Biosense Webster Inc., have also launched new products in this space over recent years that provide an edge over traditional treatments as they offer fewer side effects than anticoagulant drugs.
To conclude, while certain hurdles may limit its penetration in specific markets, such as a lack of skilled personnel to perform LAAC surgeries, developments across technology combined with much more favorable reimbursement policies could potentially drive greater adoption globally over the forecast period. Consequently, experts expect robust CAGR growth across regions through 2027, propelled by increasing acceptance among physicians and patients towards minimally invasive surgeries such as those offered by LAAC devices due to their lesser associated risks compared to traditional therapies such as anticoagulant drugs.
The report analyzes Left Atrial Appendage Closure Devices Market from the demand as well as the supply side. In supply-side analysis, we reach out to the Left Atrial Appendage Closure Devices Market players to collect information on their portfolio, revenue, target customers, and other insights. During this process, paid interviews and surveys are conducted for obtaining and validating the data pointers. We also deep dive into the available paid industry databases, research studies, white papers, and annual reports.
As a part of our demand-side analysis, we reach out to the end-users of the Left Atrial Appendage Closure Devices Market, to gauge the application areas, demand trends, and similar insights.
This business analysis report on the Left Atrial Appendage Closure Devices Market presents a regional as well as country-level analysis. The regions covered in the report are – North America, Europe, Asia Pacific and Rest of the World. In these four regions, all the countries have been covered in detail with information on Left Atrial Appendage Closure Devices Market size, trends, and forecast.
The report covers Left Atrial Appendage Closure Devices Market revenue and forecast for the period (2021 – 2028), by regions, (further split into countries):
|Left Atrial Appendage Closure Devices Market Revenue ($Million)||XX||XX||XX||XX||XX||XX||XX|
*Note – Country-level break-down has been covered in the report
There is an entire data collection and validation framework that Datavagyanik follows to provide you with authentic information. We connect to industry experts across various countries to understand market trends and demand pattern. The same is done through paid interviews and surveys.
Our internal team of analysts is experts in studying market patterns, mining data, and extracting useful information from different paid as well as freely available sources. Datavagyanik has an exhaustive internal database with information on markets, market players, and other macro and micro economic indicators that impact industries.
“Every Organization is different and so are their requirements”- Datavagyanik
Add the power of Impeccable research, become a DV client